Microbial Contamination Leads to Dr. Reddy's Recall

- Last updated on GMT

Related tags: Food and drug administration

Microbial Contamination Leads to Dr. Reddy's Recall
Five lots of a Dr Reddy’s manufactured gastric drug have been recalled due to microbial contamination.

The voluntary recall was announced last week by the US Food and Drug Administration (FDA) which said “a lot of raw material used in the manufacture of Ranitidine was positive for Pseudomonas sp."

The contaminated Ranitidine Hydrochloride Tablets – an over-the-counter drug used in gastric problems -  were manufactured at the Dr Reddy's facility in Bridgewater, New Jersey, US for distributors Wal-Mart, Supervalu and Walgreen.

Outsourcing-Pharma.com contacted India-based Dr. Reddy’s for further information but did not receive a response at the time of going to press.

Related news

Show more

Related products

show more

Empowering Clinical Trial Sponsors with Analytics

Empowering Clinical Trial Sponsors with Analytics

PerkinElmer | 14-Jul-2021 | Technical / White Paper

Is your Clinical Data Review creating problems or solving them? Take Control of Your Data. PerkinElmer Informatics Clinical Solutions, powered by Tibco...

Related suppliers

Follow us

Products

View more

Webinars